At 4:00 a.m. on a mid-March morning, while most of the country was hunkering down due to the COVID-19 pandemic, Jennifer Huber began the long drive from her home in the Hudson Valley Region of New York to Boston. With her was her 14-year-old daughter, Emma Levine, who was suffering from excruciating headaches caused by … Read more
Two things most surprised Jackie Page about her stage III ovarian cancer diagnosis in early 2019. She had no family history of the disease, and she had just turned 52 — a younger age than many women who learn they have it. What most worried her was whether she would have good options for treatment: … Read more
OK Eason doesn’t mind jokes about his unique first name, especially lately. Healthy and thriving more than 30 months after a massive tumor was found in his brain, Eason takes pleasure in telling people that he is more than just “O.K.” Eason, 69, was diagnosed with a glioblastoma in February 2018. He had surgery immediately, … Read more
Self-care — the practice of allotting time to take care of yourself and keep up with your own needs — is an important way of keeping the mind and body healthy. It is important for patients with lung cancer to practice self-care, especially during COVID-19. Here, Susanne Welsh Lobacki, LICSW, a clinical social worker at … Read more
The face of colorectal cancer is changing. Today, incidence rates of colon and rectal cancer are on the rise in young people (those under the age of 50) while decreasing in older adults (those over the age of 50). The Young-Onset Colorectal Cancer Center at Dana-Farber Brigham Cancer Center was developed to address the unique challenges facing … Read more
Excited to be the first patient in a novel clinical trial, Jon Woods is hoping that an infusion of immune natural killer cells donated by his son will beat back the metastatic cancer he has battled for four years. “I’m upbeat [and] I’m happy to be a pioneer,” says Woods, 65, a retired postal worker … Read more
Carol Brown, 80, has been through quite a turbulent 2020. Her much-beloved pastimes, including playing violin in a senior orchestra, book groups, and weekly church services, are now virtual due to the COVID-19 pandemic. The Boston-area resident had to cancel a March trip to visit family out west, and she spent the summer packing up … Read more
Tim O’Neill likes to keep moving — whether on his boat, his motorcycle, in his running shoes, or while steering an RV across 47 states. Chronic lymphocytic leukemia (CLL) has failed to stop him from these pursuits, and he’s determined not to let a pandemic do so either. “I’m more careful these days because of … Read more
For almost half of his life, Michael Murray has had to grapple with cancer, including multiple relapses. One of his hardest setbacks was hearing that his cancer had returned just weeks before he was set to start his freshman year at Boston College. With the news, Murray worried that his future would be in jeopardy. … Read more
In their quest for effective targeted therapies to treat triple-negative breast cancer (TNBC) — an aggressive disease that often doesn’t respond to standard chemotherapy — researchers at Dana-Farber and elsewhere have recently focused on the potential of drugs known as BET bromodomain inhibitors. BET inhibitors target a family of proteins including BRD2, BRD3, BRD4, and … Read more
Scott Sterling spent his entire military career pushing both his mind and body to the limit. A member of the 75th Ranger Regiment, the U.S. Army’s premier large-scale special operations force and a special mission unit within the U.S. Army Special Operations Command, Sterling was trained to endure and overcome any challenge placed in front … Read more
In 2018, Suzy Pope was diagnosed with an aggressive form of cancer known as glioblastoma. Typically forming in the brain or spinal cord, glioblastomas tend to have a fairly grim prognosis. But two and a half years after her diagnosis, Pope continues to thrive and make the most of every day. Her exceptional response to … Read more
Ependymomas are some of the most difficult-to-treat brain tumors. Mariella Filbin, MD, PhD, a neuro-oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, is driven by a desire to find new therapies for these pediatric brain tumors. At the core of her work is an effort to uncover the events that shape tumor development. Defining how … Read more
The go-to metaphor for cancer drugs known as immune checkpoint inhibitors is a brake-release lever — a means of setting loose an immune system attack on tumor cells. Helpful as it is, the analogy glosses over a highly complex mechanism involving multiple types of immune cells, cell receptors, signals, and responses — so intricate that … Read more
Treatment advances for multiple myeloma continue to bring improved outcomes for patients in different stages of their disease. Recent clinical trial reports show progress in treating two myeloma populations — newly diagnosed, transplant eligible patients, and individuals whose disease has progressed following several lines of therapy. In one trial, the phase 2 GRIFFIN study showed … Read more
The ongoing COVID-19 pandemic has resulted in a uniquely uncertain and stressful way of life for us all. Not knowing what will happen next — in addition to fear for our own health, that of our loved ones, and the disruption to our lives — can lead to distress and depression. This can be particularly … Read more
Liver cancer that develops in people with obesity and Type 2 diabetes is dependent on elevated amounts of a protein that might be targeted for treatment by two existing drugs, say Dana-Farber scientists. The research reported in Cancer Research by Pere Puigserver, PhD, and colleagues pertains specifically to liver cancer in individuals who are obese … Read more
Carly Tobin loves dancing for the fun and freedom it provides. During treatment for a rare pediatric kidney cancer known as Wilms tumor, the pre-teen’s passion also proved a vital source of strength. Diagnosed in early June 2019, Carly — now 11 and cancer-free — underwent surgery, radiation, and chemotherapy at Dana-Farber/Boston Children’s Cancer and … Read more
Due to COVID-19, Ava Girolimetti doesn’t know if she will be starting middle school this September in a classroom, on a computer screen, or a combination of both. But thanks to CAR T-cell therapy for acute lymphoblastic leukemia (ALL), she plans to be there cancer-free. The rising sixth grader can make this claim as one … Read more
There are many different treatment options available for breast cancer, including a type of surgery called a lumpectomy. While surgery can be anxiety-inducing, rest assured that lumpectomies are extremely safe and usually take no more than an hour. Here, Anna Weiss, MD, a breast surgeon in the Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham … Read more